RecallRadar

FDA Drug recall D-740-2014

Maximum Strength Comtrex , Day/Night Flu Therapy , Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Dextromethorphan HBr 10mg, Phenylephr…

On 2014-01-22 the FDA classified a Class III recall of Maximum Strength Comtrex , Day/Night Flu Therapy , Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Dextromethorphan HBr 10mg, Phenylephr… by Novartis Consumer Health, citing failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-740-2014
ClassificationClass III
Statusterminated
Initiated2013-05-15
Published2014-01-22
Last updated2026-09-13 11:51 UTC
CompanyNovartis Consumer Health
DistributionUS

Product

Maximum Strength Comtrex , Day/Night Flu Therapy , Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Dextromethorphan HBr 10mg, Phenylephrine HCL 5mg, packaged in 12 coated caplets daytime formula and 12 coated caplets nighttime formula. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2084-24.

Reason

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Identifiers

code_infoLot# 10117243 Exp 06/13 Lot# 10119333 Exp 07/13

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-740-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.